Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

survivors * Syringe 181

12th World AIDS Conference

Keyword Abstra
symptomatic long-term in Switzerland/Psychological as
mplication in long-term of HIV infection/Chronic active
sy findings in long-term with perinatal HIV/Autopsy findi
ertically infected HIV survivorship and cleansing the maternally
ammes in Canada/The SurvUDI surveillance network: 3 years of
patient care covered by SUS in Brazil, 1995-1996/The profile of Al
elation of antimicrobial susceptibilities for Mycobacterium avium
V-1 isolates to abacavir/ Susceptibility profile (AntivirogramT") of 9
HIV-1 isolates and their susceptibility to neutralization by polyclo

act -
60449
60675
60717
43485
23172
12429
22169
41226
11211

Keyword

Abstract--

ndividuals/Increased to HIV-1 infection of periphe
azole (FLU) levels with testing and clinical respons
c in Ukraine: Assessing and vulnerability/The HIV e
gal drugs in Brazil/The of 23 strains of Cryptococcu
ubtypes/In vitro drug and sequence analysis of H
herapy do not decrease to PMPA/Genotypic chang
or differences in HIV-1 /Host factors responsible fo
to the vulnerability and of African women to HIV inf
ety of efavirenz (EFV, SUSTIVATM, DMP 266) in combination with
n with efavirenz (EFV,, DMP 266) in antiretroviral ther
vity of efavirenz (EFV, Sustiva"m DMP 266) in combination with op
on of efavirenz (EFV, sustivaTM, DMP 266) and indinavir (IDV) ve
ong IDUs in the town of Svetlogorsk, Gomel region, Belarus/Sent: Bridging gap action of SWAA, Burundi/Medical care for PLWHA i
HIV-infected persons in Sweden 1986-2002. Medical care cost est
itive people/How we in built up an umbrella-organization
IDS information in SFI ( Swedish for immigrants) schools/STDs a
The sexual behaviour of men abroad/The sexual behavio
ts of isolation under the Communicable Diseases Act on t
h risk behaviour in nine prisons/Low HIV seroprevalenc
ith HIV and AIDS in the Swiss HIV cohort study/Work, income and

21156
22219
23366
31213
41211
41218
60690
60846
22334
22386
22340
22343
43467
60111
13469
34286
13502
14230
14268
23552
13336?/How often can signs, symptoms and immunological abnormaliti 1
pinal fluid/Neurological during primary HIV infection co
ndividuals experiencing /Randomized controlled trial of
ce associated with STD, Rakai community-based stud I
in women/HIV-related by injection drug use (IDU) afte
Evolution of depressive in HIV-infected patients after li
n men with non-specific at an STD clinic in Kenya/High
e common HIV-related in a nationally representative s
sociated with race, HIV and recovery from substance a
C infection/Hematocrit, and quality of life in AIDS patie
ted women/Race, HIV,recovery from drug abuse, an
d upper gastrointestinal /Self-prescribed marijuana use
als/HIV infected CD4+ syncytia are commonly found in the periph
rm twins by respiratory syncytial virus infection (RSV): A case rep
NA level/Emergence of syncytium-inducing HIV-1 variants coinci
hod for the follow-up of syncytium inducing strains in HIV patients
ncy of HIV-1 subtype C inducing (SI) phenotype amon
Stevens-Johnson (SJ) Syndrome in HIV patients with TB/Re-intr
tures of acute retroviral syndrome in La Plata, Argentina/Clinical f
/The loin pain/indinavir and urolithiasis associated with
ired immunodeficiency in Benin City, Nigeria/Clinico-e
asing trends in wasting and failure to thrive among peri
ired immunodeficiency /Neutropenia and bacterial infe
ndary traumatic stress: Understandings and coping m
red immune deficiency /Q-fever associated granuloma
cidence of hemorrhagic in HIV-infected patients/Incide
with or without wasting /Comparative study of rifabutin
men with AIDS wasting (AWS)/The effects of oxandrol
teatosis-lactic acidosis (SLAS) in early stage HIV infec
stic infection/neoplasia after haart initiation/Accelerate

174*/12169
12195
22458
524*/23372
23456
24231
33242
42213
42214
60149
60408
60634
21111
60597
60568
42192
60879
32267
12202
12388
13177
13237
22121
24302
31224
32157
32171
42335
60611
60999

nd biological factors in a cohort of asymptomatic long-term s 13355
d health care usage in a cohort of asymptomatic long-term s 13358
ad of participants of the HIV cohort study with and without a 22346
pective analysis in the HIV cohort study (SHCS)/Why is hi 446*/32335
ehaviour of French and gay men in the era of new treatment 642*/34107
gement of women in the HIV cohort study/Gynecologic man 42433
eedle distribution in the prison setting: A breakthrough?/Ne 43403
ions for CMV retinitis in AIDS patients/Pharmacoeconomic 60374
nfection controlled in a prison for women over two years/HI 60493
v subtypes in patients in Switzerland /Distribution of HIV-1 env sub 13198
pidemiology of HIV-1 in /Molecular epidemiology of H 13207
ction against HIV/AIDS,, 1997/Gay couples and prote 23128
ng drug users in Zurich, /Looking beyond needle shari 23352
anonymous test sites in /Factors associated with HIV i 23359
ch population groups in:The mediator approach. Wh 33562
on in the French part of: A pilot study/Behavioural ris 43411
sed country, the case of /HIV/AIDS discrimination in a 44170
migrant communities in:An overview/Evaluation of H 44311
r migrant populations in: Different communities, differ 60199
after AIDS diagnosis in, diagnosed between 1988 an 60253
ine year cohort study in /Molecular epidemiology of H 60413
c long-term survivors in /Psychological aspects of asy 60449
eral population study in /Evolution of HIV/AIDS protec 60733
on of virus attenuation/ Sydney blood bank cohort virus evolution 11143
m non-progression/The Blood Bank Cohort infected with a 13350
use among gay men in, Australia: The normative role of dr 14180
ranssexuals who live in /Responding to the needs of Maori 402*/14220
urses from a HIV unit in, Australia, 1993-1995/A descripti 22469
asual partners) among gay men in 1996-97/Increase in 23109
y men in Singapore and /A comparison of HIV risk between 23110
n in homosexual men in, Australia/Risk factors for HIV infe 23124
nd lesbian community: Women and Sexual Health Surve 23492
rant communities in the region/Using ethnic media to reac 589*/33445
erred from a HIV unit in, Australia, to community nurses, 1 60134
ries in the 21st century/ Symposia on HIV series in the 21st centur 60293
n with late HIV disease/ Symptom distress and self-care burden a 22462
ased chiropractic clinic/ and disability profiles of HIV pos 60512
HIV/AIDS/Developing symptom indices to assess health outcom 22465, and virologic markers/ Symptomatic HIV-1 seroconversion corre 21116
tion among a cohort of symptomatic HIV-1 infected adults in Nair 12407
me of hospitalization for HIV infection/The impact of 74*/12412
ization by patients with HIV infection in the United S 13227
nosine) in patients with HIV infection/A phase I dos 22281
of antiretroviral use in a and asymptomatic HIV infec 22366
atterns in patients with Mycobacterium avium comp 32324
HIV drug, in adults with HIV infection/The pharmac 42263
mproving quality of life in HIV patients/Homoeopathic 60179
s in patients with HIV-1 primary infection on antiretr 60316
chiatric diagnoses and symptomatology as predictors of HIV risk 23531
n HIV infected children/ Symptoms and signs of peripheral neurop 32206

pregnancy and in STD syndromes among clinic attenders at five 22190
vice advertising on STD /Developing a nationwide publ 588*/33450
ana - A new dimension/ Syndromic management of STDs in Ghan 22204
nagement utilizing STD syndromic management training in the Ph 13483,India: Implications for management/Genital ulcer dis 22199
Ds)/Community based management of reproductive tr 23381
STD care based on the approach in three West African 33233
sitivity and specificity of diagnosis of some STDs amon 79*/33235
s in early diagnosis and management of STDs/Empow 33410
e's clients availing STD case management at Clinica R 60759
ence of human serum/ Synergistic anti-HIV activity of ritonavir an 12315
tor regimens may have synergistic antiviral effects in patients - B 22350
MEA) and PMPA show or additive inhibition of HIV rep 41195
modified, HIV-1-specific syngeneic lymphocytes in HIV-1-discorda 346*/42322
erosexual populations/ Synthesis of HIV prevention intervention r 23157
elenolane nucleosides/, chiral separation and anti-HIV 41200
pression, Interleukin-2 synthesis and apoptosis in fresh or culture 12180
at protein promotes the of platelet-activating factor by h 21141
sis and type 1 cytokine /Impact of potent anti-HIV thera 219*/21169
of intracellular cytokine in CD4+ and CD8+ cell subsets 217*/21171
Macaques/Nitric oxide during acute SIVmac251 infecti 60686
ng and boosting with a synthetic peptide polymer from the C4 reg 11241
IV-negative controls/ Syphilis in HIV infection compared to HIV- 22202
ty of Sdo Paulo, Brazil/, hepatitis and HIV prevalence am 23554
Prevalence of HIV and syphilis infections among pregnant wome 13111
d, 1995-1997/HIV and incidence in men attending sexual 13152
s for seroconversion to: Results from a case-control stud 13282
93 to 1997/Declines in prevalence in pregnancy and in S 22190
w prevalence of active in a population with high prevalen 22197
diagnosis?/Congenital: Epidemiological or laboratory dia 22198
V, hepatitis B and C and infection in a different risk behavio 23379
revalence of HIV-1 and among women in Uganda/Preval 23383
aviors and serology for and HIV/Are parlor girls at risk? A 23410
actors associated with seropositivity among female sex 23509
yana/HIV infection and among female commercial sex w 23538
to human retroviral and infection among Macanao's fisher 23561
HTLV-1, HBV, HCV and among female prisoners in Brazil/ 23574
Challenges in providing and HIV counselling and testing o 33236
a rapid RPR method for screening of antenatal and STD cl 33241
ng the pathogenesis of /Immunohistochemistry as a diag 33246
sment and serology for, hepatitis B and HIV among comm 33248
do District, Kenya/HIV, and HTLV prevalence and risk fac 60210
ilical cords/Congenital and funisitis: Detection of T. pallid 60443
HIV, and HBV, HCV and among the addicted prisoners/Th 60835

I

demic spread of HIV by syringe-based drug sharing in Poland: Pa
aluation of needle- and syringe-exchange programs: Results of p
tional characteristics of Syringe Exchange Programs in Southern
ocial network formation/ exchange not associated with soc
on syringe availability/ source, re-use and discard amon
cipants in the Baltimore Exchange Program/Two-year foil

13186
410*/23178
23174
23195
23200
23229